V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280005278 | 280003413 | 1.54 | null | Palliative (P) | 2017-05-10 | 2017-06-17 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | Y | 280028815 | ERLOTINIB |
| 280005279 | 280003414 | null | 21.5 | null | 2013-10-23 | 2013-10-23 | VIDE | Y | N | 280028817 | ECF |
| 280005280 | 280003414 | 1.78 | 0 | Palliative (P) | 2015-09-08 | 2015-09-08 | FCarboSt | N | N | 280028817 | IPILIMUMAB |
| 280005281 | 280003415 | -1 | 95 | null | 2016-03-23 | 2016-04-06 | LIPOSOMAL DOXORUBICIN | N | N | 280028824 | GEMCITABINE |
| 280005282 | 280003415 | 1.7 | 97 | Palliative (P) | 2013-12-23 | 2014-01-03 | Capecitabine + Oxaliplatin 21day | Y | Y | 280028824 | CISPLATIN + PEMETREXED |
| 280005283 | 280003416 | 1.81 | 51.2 | Palliative (P) | 2016-03-10 | 2016-03-29 | Bendamustine+Rituximab (1st Course) | 02 | N | 280028827 | IPILIMUMAB |
| 280005284 | 280003416 | 1.74 | 101 | Curative (C) | 2015-12-18 | 2015-12-18 | Paclitaxel 7 day | 02 | N | 280028827 | CHOP R |
| 280005285 | 280009981 | 1.72 | null | Palliative (P) | 2014-08-26 | 2014-09-01 | DE-ESCALATE TRIAL | N | N | 280028832 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 280005286 | 280009981 | 1.77 | 79 | Palliative (P) | 2013-11-25 | 2013-12-08 | Fluorouricil + Folonic Acid (MdG) | N | N | 280028832 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 280005287 | 280003417 | 1.52 | 80.6 | Neo-adjuvant (N) | 2016-12-17 | 2017-01-01 | OST Euramos 1 Closed Trial - AP | Y | Y | 280028836 | CAPECITABINE + STREPTOZOCIN |
| 280005288 | 280003417 | null | 79.8 | Palliative (P) | 2017-08-23 | 2017-09-04 | DE-ESCALATE TRIAL | N | N | 280028836 | OXALIPLATIN + MDG |
| 280005289 | 280003417 | 1.66 | 91.4 | Curative (C) | 2016-08-17 | 2016-08-22 | Liposomal Doxorubicin (Caelyx) | 1 | N | 280028836 | CISPLATIN + ETOPOSIDE |
| 280005290 | 280003418 | 0 | 78 | Disease modification (D) | 2014-02-15 | 2014-02-25 | ECX | 02 | N | 280028839 | OXALIPLATIN + MDG |
| 280005291 | 280003418 | 1.89 | 59.95 | Palliative (P) | 2013-07-03 | 2013-07-22 | Bendamustine+Rituximab (1st Course) | 2 | N | 280028839 | OXALIPLATIN + MDG |
| 280005292 | 280003419 | 1.84 | 62 | Palliative (P) | 2016-09-12 | 2016-10-31 | EW EuroEwing 2012 Arm A VIDE | N | N | 280028846 | IPILIMUMAB + NIVOLUMAB |
| 280005293 | 280003419 | 1.75 | 84.8 | Curative (C) | 2014-03-03 | 2014-03-31 | CARBOPLATIN + GEMCITABINE | 02 | N | 280028846 | BEP |
| 280005294 | 280003420 | 1.72 | 97.4 | Palliative (P) | 2016-10-19 | 2016-11-07 | CAPECITABINE + OXALIPLATIN | N | N | 280028848 | CARBOPLATIN + PEMETREXED |
| 280005295 | 280003420 | null | 137 | Palliative (P) | 2013-07-20 | 2013-07-29 | Carbo F | N | N | 280028848 | CARBOPLATIN + PEMETREXED |
| 280005296 | 280003421 | 1.71 | 62.3 | Palliative (P) | 2014-11-18 | 2014-11-22 | Hydroxycarbamide | 02 | N | 280028851 | OXALIPLATIN + MDG |
| 280005297 | 280003422 | 1.57 | null | Palliative (P) | 2015-04-18 | 2015-05-02 | EW EuroEwing 2012 Arm A VIDE | N | N | 280028855 | PEMBROLIZUMAB |
| 280005298 | 280003422 | null | 79 | null | 2015-07-14 | 2015-08-19 | GemCarbo Days 1+8 | N | N | 280028855 | GEMCITABINE |
| 280005299 | 280003422 | 1.71 | 87.1 | Palliative (P) | 2013-05-07 | 2013-05-23 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 02 | N | 280028855 | OXALIPLATIN + MDG |
| 280005300 | 280003422 | null | null | Curative (C) | null | 2013-06-21 | CARBOPLATIN + FLUOROURACIL | null | null | 280028855 | MITOMYCIN INTRAVESICULAR |
| 280005301 | 280003423 | 1.75 | 60 | null | 2017-11-14 | 2017-11-22 | Doxorubicin + Olaratumab | 02 | N | 280028861 | CTD |
| 280005302 | 280003424 | 1.73 | 81.6 | Palliative (P) | 2017-12-20 | 2018-01-08 | Cisplatin + Etoposide (3 day) | N | N | 280028862 | CAPECITABINE |
| 280005303 | 280007799 | null | 75 | Palliative (P) | 2016-12-31 | 2017-01-01 | Gemcitabine weekly | Y | N | 280028863 | GEMCARBO |
| 280005304 | 280003425 | 1.62 | 88 | Not known (9) | 2013-08-14 | 2013-08-21 | LANREOTIDE | N | N | 280028864 | MITOMYCIN INTRAVESICULAR |
| 280005305 | 280003425 | 1.7 | 95.9 | Neo-adjuvant (N) | null | 2013-09-23 | Cyclophosphamide oral | N | N | 280028864 | OXALIPLATIN + MDG |
| 280005306 | 280003425 | 1.6 | 93 | Palliative (P) | 2015-01-13 | 2015-01-20 | DABRAFENIB | 2 | N | 280028864 | ECX |
| 280005307 | 280003425 | 1.68 | null | Palliative (P) | null | 2013-09-20 | OCTREOTIDE | null | null | 280028864 | CAPECITABINE + OXALIPLATIN |
| 280005308 | 280003426 | 1.83 | 68.2 | Neo-adjuvant (N) | null | 2016-10-27 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280028869 | BCG |
| 280005309 | 280003426 | 1.85 | 82 | Palliative (P) | 2014-10-07 | 2015-06-23 | IVADo | 02 | N | 280028869 | GEMCARBO |
| 280005310 | 280003426 | null | null | Palliative (P) | 2013-07-30 | 2013-08-12 | DE-ESCALATE TRIAL | 02 | N | 280028869 | OXALIPLATIN + MDG |
| 280005311 | 280003427 | null | 112 | Palliative (P) | 2015-01-20 | 2015-02-09 | VIDE | N | N | 280028876 | FLUOROURACIL + STREPTOZOCIN |
| 280005312 | 280003427 | 1.82 | 91.1 | null | 2017-09-09 | 2017-09-10 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 280028876 | CAPECITABINE + CARBOPLATIN |
| 280005313 | 280003428 | 1.63 | 52.3 | Palliative (P) | 2014-04-08 | 2014-04-15 | Carbo F | N | N | 280028880 | DABRAFENIB |
| 280005314 | 280007803 | 1.6 | 57 | Palliative (P) | 2011-11-28 | 2013-11-08 | Methotrexate + Vinblastine | 2 | N | 280028883 | GEMCARBO |
| 280005315 | 280003429 | 1.78 | 89 | null | 2014-10-07 | 2014-10-22 | Capecitabine + Cisplatin | N | N | 280028885 | VEMURAFENIB |
| 280005316 | 280007804 | 1.84 | null | Curative (C) | 2014-06-29 | 2014-07-27 | Oxaliplatin + Modified de Gramont | N | N | 280028886 | CISPLATIN + VINORELBINE |
| 280005317 | 280007804 | 1.67 | 85.7 | Palliative (P) | 2016-08-15 | 2016-09-06 | Oxaliplatin + Modified de Gramont | 02 | N | 280028886 | GEMCARBO |
| 280005318 | 280007804 | 1.49 | null | Palliative (P) | 2017-05-26 | 2017-06-09 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 280028886 | CISPLATIN + PEMETREXED |
| 280005319 | 280007804 | null | null | Palliative (P) | 2014-12-22 | 2014-12-26 | Cisplatin + Fluorouracil + RT 5day | N | N | 280028886 | CAPECITABINE + OXALIPLATIN |
| 280005320 | 280007804 | 1.64 | null | null | 2017-07-24 | 2017-07-24 | DE-ESCALATE TRIAL | N | N | 280028886 | CTD |
| 280005321 | 280003430 | 1.82 | 52 | Palliative (P) | 2018-11-24 | 2018-12-04 | IMATINIB | N | N | 280028893 | CISPLATIN + PEMETREXED |
| 280005322 | 280003430 | 1.61 | 62.8 | Palliative (P) | 2014-11-13 | 2014-11-17 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280028893 | GEMCITABINE |
| 280005323 | 280003430 | 1.71 | null | null | 2013-12-11 | 2013-12-15 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | null | N | 280028893 | CAPECITABINE + OXALIPLATIN |
| 280005324 | 280003430 | null | 98 | Palliative (P) | null | 2013-07-22 | LANREOTIDE | Y | N | 280028893 | PEMBROLIZUMAB |
| 280005325 | 280003431 | 1.56 | null | Palliative (P) | 2017-07-20 | 2017-07-20 | Mitomycin Intravesical | N | null | 280028902 | LANREOTIDE |
| 280005326 | 280003431 | 1.68 | null | Palliative (P) | 2017-12-17 | 2017-12-20 | CYCLOPHOSPHAMIDE | N | N | 280028902 | IPILIMUMAB |
| 280005327 | 280003432 | 1.67 | null | Palliative (P) | 2017-09-03 | 2017-10-01 | BENDAMUSTINE + RITUXIMAB | N | Y | 280028905 | GEMCITABINE |